首頁 > 市場調查報告書 > 製藥

感染疾病開發平台分析

市場調查報告書

商品編碼

1741437

蚊媒感染疾病市場按疾病類型、治療類型、最終用戶和地區分類

Mosquito Borne Disease Market, By Disease Type, By Treatment Type, By End User, By Geography

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

蚊媒感染疾病市場規模預計在 2025 年為 35.8 億美元，預計到 2032 年將達到 58.6 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 7.3%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	35.8億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年年複合成長率：	7.30%	2032年價值預測	58.6億美元

蚊媒感染疾病是全球面臨的重大公共衛生問題。這些疾病透過受感染蚊子的叮咬傳播，威脅著人類生命，並造成沉重的疾病負擔。驅蚊石板是應對蚊媒感染疾病的創新解決方案之一，它可以有效阻擋蚊蟲，並降低瘧疾、登革熱和茲卡病毒等疾病的風險。

市場動態：

由於蚊媒感染疾病率的不斷上升以及人們日益認知到其對公共健康的影響，預計全球蚊媒感染疾病市場在不久的將來將出現顯著成長。政府和醫療保健組織正在大力投資研發有效的診斷和治療方法。殺蟲劑和捕蚊器等蚊蟲控制方法的技術進步進一步促進了市場的成長。然而，也有一些挑戰需要解決。市場成長的主要限制因素之一是缺乏意識和缺乏醫療設施，尤其是在新興國家。醫療基礎設施有限、資金不足和衛生條件差助長了蚊媒感染疾病的傳播。此外，蚊子抗藥性的產生和疫苗研發的複雜性也為市場帶來了重大挑戰。

儘管面臨諸多挑戰，全球蚊媒感染疾病市場仍蘊藏著巨大的機會。新型診斷工具、治療藥物和疫苗的開發帶來了潛在的成長前景。此外，製藥公司、研究機構和政府之間的合作與夥伴關係有望加速蚊蟲控制和預防創新解決方案的開發。

本研究的主要特點

本報告對全球蚊媒感染疾病市場進行了詳細分析，並以 2024 年為基準年，給出了預測期 2025-2032 的市場規模和年複合成長率（CAGR%）。
它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
根據公司亮點、產品系列、關鍵亮點、績效和策略等參數，列出了全球蚊媒感染疾病市場的主要企業。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球蚊媒感染疾病市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球蚊媒感染疾病市場的各種策略矩陣來促進決策。

GlaxoSmithKline plc
Sanofi SA
Pfizer Inc.
Merck & Co., Inc.
Novartis AG
Johnson & Johnson
Eisai Co., Ltd
Takeda Pharmaceutical Company Limited
AstraZeneca
Valeant Pharmaceuticals International, Inc.
Mitsubishi Tanabe Pharma Corporation
Abbott
Hoffmann-La Roche Ltd
Sun Pharmaceutical Industries Ltd
Lupin Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc.
Mallinckrodt Pharmaceuticals
Serum Institute of India Pvt. Ltd.
CSL Limited
Teva Pharmaceutical Industries Ltd

第 10 章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI6241

Mosquito Borne Disease Market is estimated to be valued at USD 3.58 Bn in 2025 and is expected to reach USD 5.86 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 3.58 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.30%	2032 Value Projection:	USD 5.86 Bn

Mosquito borne disease have been a significant public health concern in several parts of the world. These diseases, transmitted through the bite of infected mosquitoes, pose a threat to human lives, and are responsible for a considerable disease burden. One innovative solution to combat mosquito borne diseases is the development of a stone slab that repels mosquitoes, and thus, offering protection to individuals. This stone slab acts as an effective barrier against mosquitoes, reducing the risk of diseases such as malaria, dengue fever, and Zika virus.

Market Dynamics:

Global mosquito borne disease market is expected to witness significant growth in the near future due to increasing incidence of mosquito-borne diseases, coupled with growing awareness about their impact on public health. Governments and healthcare organizations are investing heavily in research and development to develop effective diagnostics and treatment options. Technological advancements in mosquito control methods such as insecticides and mosquito traps are further contributing to market growth. However, there are also several challenges that need to be addressed. One of the major restraints for the market growth is the lack of awareness and access to healthcare facilities, particularly in developing countries. Limited healthcare infrastructure, inadequate funding, and poor sanitation contribute to the spread of mosquito-borne diseases. Furthermore, the development of drug resistance in mosquitoes and the complexity of vaccine development pose significant challenges to the market.

Despite these challenges, there are significant opportunities in the global mosquito borne disease market. The development of new diagnostic tools, therapeutic drugs, and vaccines offers potential growth prospects. Moreover, collaborations and partnerships between pharmaceutical companies, research institutions, and governments are likely to accelerate the development of innovative solutions for mosquito control and prevention.

Key features of the study:

This report provides in-depth analysis of the global mosquito borne disease market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global mosquito borne disease market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline plc, Sanofi S.A., Pfizer Inc., Merck & Co., Inc., Novartis AG, Johnson & Johnson, Eisai Co., Ltd, Takeda Pharmaceutical Company Limited, AstraZeneca, Valeant Pharmaceuticals International, Inc., Mitsubishi Tanabe Pharma Corporation, Abbott , F. Hoffmann-La Roche Ltd, Sun Pharmaceutical Industries Ltd, Lupin Pharmaceuticals, Inc., BioCryst Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Serum Institute of India Pvt. Ltd., CSL Limited, and Teva Pharmaceutical Industries Ltd
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global mosquito borne disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mosquito borne disease market

Mosquito Borne Disease Market Detailed Segmentation:

By Disease Type:
- Malaria
- Dengue
- Yellow Fever
- West Nile Virus
- Chikungunya
- Zika Virus
- Others
By Treatment Type:
- Medication
- Vaccination
- Vector Control Methods
- Immunotherapy
- Supportive Care
- Others
By End User:
- Hospitals
- Clinics
- Diagnostic Centers
- Research Institutes
- Government Organizations
- NGOs
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- GlaxoSmithKline plc
- Sanofi S.A.
- Pfizer Inc.
- Merck & Co., Inc.
- Novartis AG
- Johnson & Johnson
- Eisai Co., Ltd
- Takeda Pharmaceutical Company Limited
- AstraZeneca
- Valeant Pharmaceuticals International, Inc.
- Mitsubishi Tanabe Pharma Corporation
- Abbott
- F.Hoffmann-La Roche Ltd
- Sun Pharmaceutical Industries Ltd
- Lupin Pharmaceuticals, Inc.
- BioCryst Pharmaceuticals, Inc.
- Mallinckrodt Pharmaceuticals
- Serum Institute of India Pvt. Ltd.
- CSL Limited
- Teva Pharmaceutical Industries Ltd

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Mosquito Borne Disease, By Disease Type
- Market Mosquito Borne Disease, By Treatment Type
- Market Mosquito Borne Disease, By End User
- Market Mosquito Borne Disease, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Mosquito Borne Disease Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Mosquito Borne Disease Market, By Disease Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Malaria
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Dengue
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Yellow Fever
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
West Nile Virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Chikungunya
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Zika Virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Mosquito Borne Disease Market, By Treatment Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Vaccination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Vector Control Methods
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bin)
Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Supportive Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Mosquito Borne Disease Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Government Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
NGOs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Mosquito Borne Disease Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Eisai Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Valeant Pharmaceuticals International, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Mitsubishi Tanabe Pharma Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sun Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Lupin Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BioCryst Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Mallinckrodt Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Serum Institute of India Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
CSL Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

FAQ

蚊媒感染疾病市場按疾病類型、治療類型、最終用戶和地區分類

Mosquito Borne Disease Market, By Disease Type, By Treatment Type, By End User, By Geography

市場動態：

本研究的主要特點

目錄

第1章調查目的與前提條件

第2章市場展望

第3章市場動態、法規與趨勢分析

4. 全球蚊媒感染疾病市場-冠狀病毒（COVID-19）大流行的影響

5. 2020-2032 年全球蚊媒感染疾病市場（依疾病類型）

6. 2020-2032 年全球蚊媒感染疾病市場（依治療類型）

7. 2020 年至 2032 年全球蚊媒感染疾病市場（依最終使用者分類）

8. 2020-2032 年全球蚊媒感染疾病市場（按地區）

第9章競爭態勢

第 10 章章節

Market Dynamics:

Key features of the study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Mosquito Borne Disease Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Mosquito Borne Disease Market, By Disease Type, 2020-2032, (US$ Bn)

6. Global Mosquito Borne Disease Market, By Treatment Type, 2020-2032, (US$ Bn)

7. Global Mosquito Borne Disease Market, By End User, 2020-2032, (US$ Bn)

8. Global Mosquito Borne Disease Market, By Region, 2020-2032, (US$ Bn)

9. Competitive Landscape

10. Section

蚊媒感染疾病市場按疾病類型、治療類型、最終用戶和地區分類

Mosquito Borne Disease Market, By Disease Type, By Treatment Type, By End User, By Geography

市場動態：

本研究的主要特點

目錄

第1章 調查目的與前提條件

第2章 市場展望

第3章市場動態、法規與趨勢分析

4. 全球蚊媒感染疾病市場-冠狀病毒（COVID-19）大流行的影響

5. 2020-2032 年全球蚊媒感染疾病市場（依疾病類型）

6. 2020-2032 年全球蚊媒感染疾病市場（依治療類型）

7. 2020 年至 2032 年全球蚊媒感染疾病市場（依最終使用者分類）

8. 2020-2032 年全球蚊媒感染疾病市場（按地區）

第9章 競爭態勢

第 10 章 章節

Market Dynamics:

Key features of the study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Mosquito Borne Disease Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Mosquito Borne Disease Market, By Disease Type, 2020-2032, (US$ Bn)

6. Global Mosquito Borne Disease Market, By Treatment Type, 2020-2032, (US$ Bn)

7. Global Mosquito Borne Disease Market, By End User, 2020-2032, (US$ Bn)

8. Global Mosquito Borne Disease Market, By Region, 2020-2032, (US$ Bn)

9. Competitive Landscape

10. Section

第1章調查目的與前提條件

第2章市場展望

第9章競爭態勢

第 10 章章節